[HTML][HTML] Fats, friends or foes: investigating the role of short-and medium-chain fatty acids in Alzheimer's disease

AO Ameen, K Freude, BI Aldana - Biomedicines, 2022 - mdpi.com
Characterising Alzheimer's disease (AD) as a metabolic disorder of the brain is gaining
acceptance based on the pathophysiological commonalities between AD and major …

[HTML][HTML] Potential benefits of medium chain fatty acids in aging and neurodegenerative disease

E Dunn, B Zhang, VK Sahota… - Frontiers in Aging …, 2023 - ncbi.nlm.nih.gov
Neurodegenerative diseases are a large class of neurological disorders characterized by
progressive dysfunction and death of neurones. Examples include Alzheimer's disease …

[HTML][HTML] The impact of medium chain and polyunsaturated ω-3-fatty acids on amyloid-β deposition, oxidative stress and metabolic dysfunction associated with …

J Mett - Antioxidants, 2021 - mdpi.com
Alzheimer's disease (AD), the most common cause of dementia in the elderly population, is
closely linked to a dysregulated cerebral lipid homeostasis and particular changes in brain …

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis

CB Castro, CB Dias, H Hillebrandt, HR Sohrabi… - Nutrition …, 2023 - academic.oup.com
Abstract Context In preclinical Alzheimer's disease (AD), the brain gradually becomes
insulin resistant. As a result, brain glucose utilization is compromised, causing a cellular …

[HTML][HTML] Fatting the brain: a brief of recent research

G Hussain, F Schmitt, JP Loeffler… - Frontiers in cellular …, 2013 - frontiersin.org
Fatty acids are of paramount importance to all cells, since they provide energy, function as
signaling molecules, and sustain structural integrity of cellular membranes. In the nervous …

Fatty acid metabolism in the progression and resolution of CNS disorders

JFJ Bogie, M Haidar, G Kooij, JJA Hendriks - Advanced drug delivery …, 2020 - Elsevier
Recent advances in lipidomics and metabolomics have unveiled the complexity of fatty acid
metabolism and the fatty acid lipidome in health and disease. A growing body of evidence …

Fatty acids and beyond: Age and Alzheimer's disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition

KLM Ooi, K Vacy, WC Boon - Neurochemistry International, 2021 - Elsevier
Lipids are essential in maintaining brain function, and lipid profiles have been reported to be
altered in aged and Alzheimer's disease (AD) brains as compared to healthy mature brains …

[HTML][HTML] Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study

SG Snowden, AA Ebshiana, A Hye, Y An… - PLoS …, 2017 - journals.plos.org
Background The metabolic basis of Alzheimer disease (AD) pathology and expression of AD
symptoms is poorly understood. Omega-3 and-6 fatty acids have previously been linked to …

Dietary fiber and microbiota metabolite receptors enhance cognition and alleviate disease in the 5xFAD mouse model of Alzheimer's disease

Y Zhou, L Xie, J Schröder, IS Schuster… - Journal of …, 2023 - Soc Neuroscience
Alzheimer's disease (AD) is a neurodegenerative disorder with poorly understood etiology.
AD has several similarities with other “Western lifestyle” inflammatory diseases, where the …

Fatty acids and their therapeutic potential in neurological disorders

E Lei, K Vacy, WC Boon - Neurochemistry international, 2016 - Elsevier
There is little doubt that we are what we eat. Fatty acid supplementation and diets rich in fatty
acids are being promoted as ways to a healthier brain. Short chain fatty acids are a product …